Research
environment
Research
environment
The
potential for conducting Clinical trials in Turkey is enormous with a population
of >70 million
and a huge potential with regards to
-
Patients
-
Experienced investigators
-
Fully equipped hospitals
Actually, about 500 to 600 clinical trials are performed per year.
There are 94
universities, 59 medical schools,
1190 hospitals, 200.000 hospital beds and 95,100 medical doctors, 46% of which
have a specialization.
As
important advantage Turkey offers are the availability of well- equipped and
high level university and state hospitals, well-trained specialized clinicians,
lower costs associated with ethical reviews, regulatory approvals and
investigator compensation, and a good success rate for patient recruitment.
Regulatory
and Ethics
As Turkey is a nominee to join the EU in the future, regulations for clinical trials have been modified by the government in DEC 2008, in order to comply with EU regulations (Directive 2001/20/EC).
There is a single (regional) Ethics Committee’s opinion for all sites which dramatically reduces the current timelines, and private hospitals will be allowed to conduct clinical trials, too. EC's and MoH's approval process go in paralell and should not take longer than 60 days.
ICH-GCP
has been implemented already a long time ago and compliance with is supervised
closely by ECs and the MoH.
Local
Partner CRO
Kuantum
CRO Ltd. Sti.
I.A.O.S.B.
10032 Sok. No:9
35620
Cigli Izmir-TURKEY
Tel
+90 232 328 35 30
Fax
+90 232 328 35 34
Email
bd@kuantum-cro.com
CRO
services provided in Turkey
Request
for clinical trial authorisation and EC opinion, feasibility
survey, site selection and set-up, on-site monitoring, national project
management, supply logistics (complete warehouse facilities)
Links